Halotestin

Halotestin

 [hal″o-tes´tin]
trademark for a preparation of fluoxymesterone, an androgen used in the palliative treatment of metastatic breast cancer and in replacement therapy for male hypogonadism and delayed male puberty.
Mentioned in ?
References in periodicals archive ?
Holland, "One-day VATH (vinblastine, adriamycin, thiotepa, and halotestin) therapy for advanced breast cancer refractory to chemotherapy," Cancer, vol.
"I recommend Halotestin not to exceed 2 mg, methyltestosterone not to exceed 2.5 mg, or Estratest half-strength or full strength," Dr.